Statistics

Total Visits

Views
Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study59

Select a period of time:

Number of views in the range

Views
Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study34

Views

Views
December 20246
January 20251
February 20251
March 202516
April 20253
May 20255
June 20252
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
United States8
United Kingdom3
Brazil2
United Arab Emirates2
Germany1
Spain1
Hong Kong1
 

Top cities views

Views
London2
Bauru1
Campo Novo do Parecis1
Cincinnati1
Council Bluffs1
Fort Wayne1
Hong Kong1
Kissimmee1
New Bedford1
Orange Park1